NDC 70518-2239-1 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-2239
- Requested NDC
- 70518-2239-1
- Package NDCs from labels
- 70518-2239-1, 70518-2239-0, 70518-2239-2
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2021-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam Tablets, USP C-IV | REMEDYREPACK INC. | 2021-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 70518-2239-0 | 2023-03-08 | Lorazepam Tablets, USP C-IV |
| 70518-2239-2 | 2023-03-08 | Lorazepam Tablets, USP C-IV |
| 70518-2239-0 | 2023-01-30 | Lorazepam Tablets, USP C-IV |
| 70518-2239-2 | 2023-01-30 | Lorazepam Tablets, USP C-IV |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Civica, Inc. | 5140798d-8571-41fb-84a4-e182aac3f64c | 2026-11-09 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 1f79a5a1-0c40-45cf-8994-51f5ba3a5938 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 08a30230-fc95-9025-e063-6394a90ae21b | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PAI Holdings, LLC dba PAI Pharma | 711b60a3-028d-41d4-aa17-8f976e6df23e | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | SUN PHARMACEUTICAL INDUSTRIES INC | 0c1caa9c-9ef1-459c-86c3-adb939130a9f | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7afd9a59-3463-4eda-8cf3-ef90be05de3d | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | ANDA072927 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7999b9c3-6185-4e4e-a4c3-d5d33d6c31d6 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0681c8db-ff09-4258-a5e0-76a26b0ea0af | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 1009c870-fd98-4e3b-81c8-4184036fb8c2 | 2026-09-30 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | ac1f88c2-2cf2-47de-a612-946cd4503090 | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Unit Dose Solutions, Inc. | 5c2cc4eb-cc84-f08c-e063-6394a90a605b | 2026-09-23 | Boxed warning, Warnings, Adverse reactions | ANDA072927 O26FZP769L |
| Ativan | LORAZEPAM | Hikma Pharmaceuticals USA Inc. | 5fc0e987-61c9-40c4-b0d5-fcea07c8733e | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Clinical Solutions Wholesale, LLC | c0810422-b732-4c04-97d8-c1521c401ef4 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 86630bdd-13ad-4ab5-9e94-fcf2ea2113e1 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 5a02c97d-637d-43f7-803c-afe4381ccc59 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 6c5356b1-c199-49ad-bb00-fd67c6691f74 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | ANDA072927 O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | ed37d304-04cf-43ec-a58d-d72002ff889b | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LORAZEPAM | LORAZEPAM | Preferred Pharmaceuticals Inc. | 903351ae-1bb0-4ac0-8430-df24cf2eee76 | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | be9f8bda-1cd9-40a6-a4da-b5961389fb5b | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | ANI Pharmaceuticals, Inc. | 787240e9-67b5-4af3-b16d-7cf314e3f2e3 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.